HomeNewsIndiaVande Bharat Mission | Private airlines may repatriate Indians stuck abroad: Report

Vande Bharat Mission | Private airlines may repatriate Indians stuck abroad: Report

Airlines will have to take approval from the Directorate General of Civil Aviation (DGCA) before any such flight

May 20, 2020 / 17:02 IST
Story continues below Advertisement

The government may soon allow private airlines to join the Vande Bharat Mission. This may be a welcome move for domestic carriers who earlier sought permission to participate.

An announcement is expected soon as Aviation Secretary Pradeep Singh Kharola discussed the issue during a ministry meeting on May 20, The Economic Times reported.

Story continues below Advertisement

Discussions about fares and flights that private carriers would operate is under discussion and “will be announced soon,” a government official told the paper. Presently, Air India and subsidiary Air India Express hold monopoly on the mission. In the updated plan, the national carrier could focus on long haul rescues, while private carriers concentrate on short-haul spots.

Airlines will have to take approval from the Directorate General of Civil Aviation (DGCA) before any such flight, another official added.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show